SOLID COMPOSITION FOR ORAL ADMINISTRATION CONTAINING IBANDRONIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND VITAMIN D.

摘要

The present invention relates to an improved solid pharmaceutical composition for oral administration comprising ibandronic acid or a pharmaceutically acceptable salt thereof, vitamin D and medium chain triglycerides or totally or partially hydrogenated oils which confer desirable physico-chemical properties to a solid formulation for oral administration suitable for the treatment of bone diseases and disorders of calcium metabolism.